Pacific Radiance Future Growth
Future criteria checks 2/6
Pacific Radiance's earnings are forecast to decline at 80.7% per annum while its annual revenue is expected to grow at 21% per year. EPS is expected to decline by 42.4% per annum. Return on equity is forecast to be 5.4% in 3 years.
Key information
-80.7%
Earnings growth rate
-42.4%
EPS growth rate
Energy Services earnings growth | 14.2% |
Revenue growth rate | 21.0% |
Future return on equity | 5.4% |
Analyst coverage | Low |
Last updated | 11 Dec 2024 |
Recent future growth updates
No updates
Recent updates
Investors Appear Satisfied With Pacific Radiance Ltd.'s (SGX:RXS) Prospects As Shares Rocket 33%
Oct 09Why Investors Shouldn't Be Surprised By Pacific Radiance Ltd.'s (SGX:RXS) 29% Share Price Surge
Aug 13Pacific Radiance Ltd. (SGX:RXS) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jun 03Pacific Radiance's (SGX:RXS) Weak Earnings Might Be Worse Than They Appear
Apr 22Even With A 30% Surge, Cautious Investors Are Not Rewarding Pacific Radiance Ltd.'s (SGX:RXS) Performance Completely
Mar 11Investors Don't See Light At End Of Pacific Radiance Ltd.'s (SGX:RXS) Tunnel And Push Stock Down 27%
Nov 27Why Pacific Radiance's (SGX:RXS) Healthy Earnings Aren’t As Good As They Seem
Nov 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 56 | 3 | 9 | 13 | 1 |
12/31/2025 | 56 | 5 | 11 | 10 | 2 |
12/31/2024 | 43 | 17 | -8 | 14 | 2 |
6/30/2024 | 34 | 27 | 2 | 21 | N/A |
3/31/2024 | 33 | 20 | -2 | 10 | N/A |
12/31/2023 | 31 | 15 | 4 | 9 | N/A |
9/30/2023 | 32 | 4 | 5 | 6 | N/A |
6/30/2023 | 31 | 307 | 11 | 11 | N/A |
3/31/2023 | 34 | 307 | 11 | 11 | N/A |
12/31/2022 | 30 | 325 | 1 | 2 | N/A |
9/30/2022 | 24 | 324 | 4 | 4 | N/A |
6/30/2022 | 19 | 16 | -4 | -4 | N/A |
3/31/2022 | 12 | 12 | 0 | -1 | N/A |
12/31/2021 | 10 | 1 | 6 | 6 | N/A |
9/30/2021 | -33 | 16 | 11 | 10 | N/A |
6/30/2021 | -18 | 6 | 7 | 8 | N/A |
3/31/2021 | -5 | 1 | 8 | 9 | N/A |
12/31/2020 | 9 | -6 | 6 | 7 | N/A |
9/30/2020 | 71 | -76 | 6 | 6 | N/A |
6/30/2020 | 71 | -75 | 11 | 11 | N/A |
3/31/2020 | 76 | -78 | 7 | 8 | N/A |
12/31/2019 | 75 | -85 | -1 | 0 | N/A |
9/30/2019 | 69 | -103 | -6 | -2 | N/A |
6/30/2019 | 69 | -96 | -12 | -9 | N/A |
3/31/2019 | 65 | -91 | -11 | -9 | N/A |
12/31/2018 | 61 | -99 | -10 | -9 | N/A |
9/30/2018 | 65 | -320 | -12 | -10 | N/A |
6/30/2018 | 64 | -329 | -9 | -8 | N/A |
3/31/2018 | 65 | -331 | N/A | -16 | N/A |
12/31/2017 | 68 | -333 | N/A | -23 | N/A |
9/30/2017 | 61 | -72 | N/A | -32 | N/A |
6/30/2017 | 63 | -77 | N/A | -42 | N/A |
3/31/2017 | 65 | -127 | N/A | -43 | N/A |
12/31/2016 | 69 | -119 | N/A | -45 | N/A |
9/30/2016 | 79 | -85 | N/A | -53 | N/A |
6/30/2016 | 94 | -65 | N/A | -35 | N/A |
3/31/2016 | 109 | -5 | N/A | -23 | N/A |
12/31/2015 | 122 | 4 | N/A | 19 | N/A |
9/30/2015 | 137 | 11 | N/A | 67 | N/A |
6/30/2015 | 148 | 23 | N/A | 68 | N/A |
3/31/2015 | 162 | 53 | N/A | 87 | N/A |
12/31/2014 | 172 | 68 | N/A | 62 | N/A |
9/30/2014 | 177 | 80 | N/A | 62 | N/A |
6/30/2014 | 182 | 77 | N/A | 34 | N/A |
3/31/2014 | 179 | 66 | N/A | 34 | N/A |
12/31/2013 | 169 | 57 | N/A | 29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RXS's earnings are forecast to decline over the next 3 years (-80.7% per year).
Earnings vs Market: RXS's earnings are forecast to decline over the next 3 years (-80.7% per year).
High Growth Earnings: RXS's earnings are forecast to decline over the next 3 years.
Revenue vs Market: RXS's revenue (21% per year) is forecast to grow faster than the SG market (3.7% per year).
High Growth Revenue: RXS's revenue (21% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RXS's Return on Equity is forecast to be low in 3 years time (5.4%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 13:32 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pacific Radiance Ltd. is covered by 10 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Meghana Kande | CGS International |
Royston Tan | Daiwa Securities Co. Ltd. |
Suvro Sarkar | DBS Bank Ltd |